Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients

Kidney International

Volumn 57, Issue 4, 2000, Pages 1727-1735

  Suliman, Mohamed E ^a   Qureshi, A Rashid ^a   Bárány, Peter ^a   Stenvinkel, Peter ^a   Divino Filho, José C ^a   Anderstam, Björn ^a   Heimbürger, Olof ^a   Lindholm, Bengt ^a   Bergström, Jonas ^a,b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular disease; End stage renal disease; Hemodialysis; Homocysteine; Malnutrition; Protein intake; Serum albumin

Indexed keywords

CYSTEINE; METHIONINE; SERINE; TAURINE;

ADULT; AGED; AMINO ACID BLOOD LEVEL; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; HEMODIALYSIS; HUMAN; HYPERHOMOCYSTEINEMIA; HYPOALBUMINEMIA; KIDNEY FAILURE; MALE; MALNUTRITION; MORTALITY; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN INTAKE;

EID: 0034033115     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00018.x     Document Type: Conference Paper

References (46)

1. 1. CLARKE R, DALY L, ROBINSON K, NAUGHTEN E, CAHALANE S, FOWLER B, GRAHAM I: Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 324:1149-1155, 1991
2. 2. BOUSHEY CJ, BERESFORD SAA, OMENN GS, MOTULSKY AG: Quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274:1049-1057, 1995
3. 3. LENTZ SR: Homocysteine and vascular dysfunction. Life Sci 61:1205-1215, 1997
4. 4. PARFREY PS: Cardiac and cerebrovascular disease in chronic uremia. Am J Kidney Dis 21:77-80, 1993
5. 5. BERGSTRÖM J, LINDHOLM B: Malnutrition, cardiac disease and mortality: An integrated point of view. Am J Kidney Dis 32:1-10, 1998
6. 6. BOSTOM AG, SHEMIN D, LAPANE KL, SUTHERLAND P, NADEAU MR, WILSON PWF, YOBURN D, BAUSSERMAN L, TOFLER G, JACQUES PF, SELHUB J, ROSENBERG IH: Hyperhomocysteinemia, hyperfibrinogenemia and lipoprotein (a) excess in maintenance dialysis patients: A matched case-control study. Atherosclerosis 125:91-101, 1996
7. 7. QURESHI AR, ALVESTRAND A, DANIELSSON A, DIVINO-FILHO JC, GUTIERREZ A, LINDHOLM B, BERGSTRÖM J: Factors predicting malnutrition in hemodialysis patients: A cross-sectional study. Kidney Int 53:773-782, 1998
8. 8. GOTCH FA: Kinetic modeling in hemodialysis, in Clinical Dialysis, edited by NISSENSON AR, FINE RN, GENTILE DE, Norwalk, Appleton & Lange, 1995, pp 156-188
9. 9. DETSKY AS, BAKER JP, MENDELSON RA, JOHNSTON N, WOLMAN SL, WESSON DE, WHITTAKER S, JEEJEEBHOY KN: Evaluating the accuracy of nutritional assessment technique applied to hospitalized patients: Methodology and comparisons. J Parenter Enteral Nutr 8:153-159, 1984
10. 10. MARCKMANN P: Nutritional status of patients on hemodialysis and peritoneal dialysis. Clin Nephrol 29:75-78, 1988
11. 11. YOUNG GA, KOPPLE JD, LINDHOLM B, VONESH E, DE VECCHI A, SCALAMOGNA A, CASTELNOVA C, OREOPOULOS DG, ANDERSON GH, BERGSTRÖM J, DICHIRO J, GENTILE D, NISSENSON A, SAKHRANI L, BROWNJOHN AM, NOLPH KD, PROWANT BF, ALGRIM CE, MARTIS L, SERKES KD: Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study. Am J Kidney Dis 17:462-471, 1991
12. 12. Metropolitan Height and Weight Tables, Stat Bull 64. Metropolitan Life Insurance Company, 1983
13. 13. SULIMAN ME, ANDERSTAM B, BERGSTRÖM J: Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patients. Kidney Int 50:1713-1717, 1996
14. 14. UBBINK JB, VERMAAK WJH, BISSBORT S: Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 565:441-446, 1991
15. 15. SELHUB J, JACQUES PF, WILSON PWF, RUSH D, ROSENBERG IH: Vitamin status and intake as primary determinants of homocysteine in an elderly population. JAMA 270:2693-2698, 1993
16. 16. HULTBERG B, ANDERSSON A, STERNER G: Plasma homocysteine in renal failure. Clin Nephrol 40:230-235, 1993
17. 17. BOSTOM A, BROSNAN JT, HALL B, NADEAU MR, SELHUB J: Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 116:59-62, 1995
18. 18. GUTTORMSEN AB, SVARSTAD E, UELAND PM, REFSUM H: Elimination of homocysteine from plasma in subjects with end stage renal failure. Ir J Med Sci 164(Suppl 15):8-9, 1995
19. 19. GULDENER CV, DONKER AJM, JAKOBS C, TEERLINK T, MEER KD, STEHOUWER CDA: No net renal extraction of homocysteine in fasting humans. Kidney Int 54:166-169, 1998
20. 20. PERNA AF, INGROSSO D, GALLETTI P, ZAPPIA V, DE SANTO NG: Membrane protein damage and methylation reactions in chronic renal failure. Kidney Int 50:358-366, 1996
21. 21. HULTBERG B, AGARDH A, ANDERSSON A, BRATTSTRÖM L, ISAKSSON A, ISRAELSSON B, AGARDH CD: Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type 1 diabetes mellitus. Scand J Clin Lab Invest 51:277-282, 1991
22. 22. SULIMAN ME, DIVINO FILHO JC, BARANY P, ANDERSTAM B, LINDHOLM B, BERGSTRÖM J: Effects of high-dose folic acid and pyridoxine on plasma and erythrocyte sulfur amino acids in hemodialysis patients. J Am Soc Nephrol 10:1287-1296, 1999
23. 23. SULIMAN ME, ANDERSTAM B, LINDHOLM B, BERGSTRÖM J: Total, free and protein-bound sulphur amino acids in uremic patients. Nephrol Dial Transplant 12:2332-2338, 1997
24. 24. ALVESTRAND A, FÜRST P, BERGSTRÖM J: Plasma and muscle free amino acids in uremia: Influence of nutrition with amino acids. Clin Nephrol 18:297-305, 1982
25. 25. LINDHOLM B, ALVESTRAND A, FÜRST P, BERGSTRÖM J: Plasma and muscle free amino acids during continuous ambulatory peritoneal dialysis. Kidney Int 35:1219-1226, 1989
26. 26. BERGSTRÖM J, ALVESTRAND A, FÜRST P, LINDHOLM B: Sulphur amino acids in plasma and muscle in patients with chronic renal failure: Evidence for taurine depletion. J Intern Med 226:189-194, 1989
27. 27. VAN GULDENER C, KULIK W, BERGER R, DIJKSTRA DA, JAKOBS C, REIJNGOUD DJ, DONKER AJ, STEHOUWER CD, DE MEER K: Homocysteine and methionine metabolism in ESRD: A stable isotope study. Kidney Int 56:1064-1071, 1999
28. 28. UELAND PM, MANSOOR MA, GUTTORMSEN AB, MULLER F, AUKRUST P, REFSUM H, SVARDAL AM: Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status: A possible element of the extracellular antioxidant defense system. J Nutr 126:1281S-1284S, 1996
29. 29. UELAND PM, REFSUM H: Plasma homocysteine, a risk factor for vascular disease: Plasma levels in health, disease and drug therapy. J Lab Clin Med 114:473-501, 1989
30. 30. REFSUM H, HELLAND S, UELAND PM: Radioenzymatic determination of homocysteine in plasma and urine. Clin Chem 31:624-628, 1985
31. 31. KLEIN S: The myth of serum albumin as a measure of nutritional status. Gastroenterology 99:1845-1846, 1990
32. 32. KAYSEN GA, RATHORE V, SHEARAR GC, DEPNER TA: Mechanism of hypoalbuminemia in hemodialysis patients. Kidney Int 48:510-516, 1995
33. 33. BERGSTRÖM J: Nutrition and mortality in hemodialysis. J Am Soc Nephrol 6:1329-1341, 1995
34. 34. BRATTSTRÖM L, LINDGREN A, ISRAELSSON B, ANDERSSON A, HULTBERG B: Homocysteine and cysteine: Determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 236:633-641, 1994
35. 35. ROBINSON K, GUPTA A, DENNIS V, ARHEART K, GREEN R, VIGO P, MAYER EL, SELHUB J, KUTNER M, JACOBSEN DW: Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 94:2743-2748, 1996
36. 36. CHAUVEAU P, CHADEFAUX B, COUDE M, AUPETIT J, HANNEDOUCHE T, KAMOUN P, JUNGERS P: Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 43(Suppl 41):S72-S77, 1993
37. 37. BACHMANN J, TEPEI M, RAIDT H, RIEZLER R, GRAEFE U, LANGER K, ZIDEK W: Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephrol 6:121-125, 1995
38. 38. ARNADOTTIR M, HULTBERG B, VLADOV V, NILSSON-EHLE P, THYSELL H: Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients. Transplantation 61:509-512, 1996
39. 39. JUNGERS P, CHAUVEAU P, BANDIN O, CHADEFAUX B, AUPETIT J, LABRUNIE M, DESCAMPS-LATSCHA B, KAMOUN P: Hyperhomocysteinemia is associated with atherosclerotic occlusive arterial accidents in predialysis chronic renal failure patients. Miner Electrolyte Metab 23:170-173, 1997
40. 40. BOSTOM AG, SHEMIN D, VERHOEF P, NADEAU MR, JACQUES PF, SELHUB J, DWORKIN L, ROSENBERG IH: Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients: A prospective study. Arteriosc Thromb Vasc Biol 17:2554-2558, 1997
41. 41. MOUSTAPHA A, NASO A, NAHLAWI M, GUPTA A, ARHEART K, JACOBSEN DW, ROBINSON K, DENNIS VW: Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 97:138-141, 1998
42. 42. BOSTOM AG, SHEMIN D, LAPANE KL, NADFAU MR, SUTHERLAND P, CHAN J, ROZEN R, YOBURN D, JACQUES PF, SELHUB J, ROSENBERG IH: Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients. Atherosclerosis 123:193-202, 1996
43. 43. FOLEY RN, PARFREY PS, HARNETT JD, KENI GM, MURRAY DC, BARRE PE: Hypoalbuminemia, cardiac morbidity and mortality in end-stage renal disease. J Am Soc Nephrol 7:728-736, 1996
44. 44. FREEMAN LM, ROUBENOFF R: The nutrition implications of cardiac cachexia. Nutr Rev 52:340-347, 1994
45. 45. NYGÅRD O, NORDREHAUG JE, REFSUM H, UELAND PM, FARSTAD M, VOLLSET SE: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230-236, 1997
46. 46. SIRRS S, DUNCAN L, DJURDJEV O, NUSSBAUMER G, GANZ G, FRÖHLICH J, LEVIN A: Homocyst(e)ine and vascular access complications in haemodialysis patients: Insights into a complex metabolic relationship. Nephrol Dial Transplant 14:738-743, 1999